chrX-153930079-CACT-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PM1PM4_SupportingBS2
The ENST00000464845.6(NAA10):βc.613_615delβ(p.Ser205del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.0000124 in 1,208,894 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (β ).
Frequency
Genomes: π 0.0000090 ( 0 hom., 0 hem., cov: 22)
Exomes π: 0.000013 ( 0 hom. 4 hem. )
Consequence
NAA10
ENST00000464845.6 inframe_deletion
ENST00000464845.6 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.61
Genes affected
NAA10 (HGNC:18704): (N-alpha-acetyltransferase 10, NatA catalytic subunit) N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes an N-terminal acetyltransferase that functions as the catalytic subunit of the major amino-terminal acetyltransferase A complex. Mutations in this gene are the cause of Ogden syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
ARHGAP4 (HGNC:674): (Rho GTPase activating protein 4) This gene encodes a member of the rhoGAP family of proteins which play a role in the regulation of small GTP-binding proteins belonging to the RAS superfamily. The protein encoded by the orthologous gene in rat is localized to the Golgi complex and can redistribute to microtubules. The rat protein stimulates the activity of some Rho GTPases in vitro. Genomic deletions of this gene and a neighboring gene have been found in patients with nephrogenic diabetes insipidus. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
PM1
In a chain N-alpha-acetyltransferase 10 (size 234) in uniprot entity NAA10_HUMAN there are 45 pathogenic changes around while only 5 benign (90%) in ENST00000464845.6
PM4
Nonframeshift variant in NON repetitive region in ENST00000464845.6. Strenght limited to Supporting due to length of the change: 1aa.
BS2
High Hemizygotes in GnomAdExome4 at 4 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAA10 | NM_003491.4 | c.613_615del | p.Ser205del | inframe_deletion | 8/8 | ENST00000464845.6 | NP_003482.1 | |
NAA10 | NM_001256119.2 | c.568_570del | p.Ser190del | inframe_deletion | 7/7 | NP_001243048.1 | ||
NAA10 | NM_001256120.2 | c.595_597del | p.Ser199del | inframe_deletion | 8/8 | NP_001243049.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAA10 | ENST00000464845.6 | c.613_615del | p.Ser205del | inframe_deletion | 8/8 | 1 | NM_003491.4 | ENSP00000417763 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000903 AC: 1AN: 110779Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32949
GnomAD3 genomes
AF:
AC:
1
AN:
110779
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
32949
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000127 AC: 14AN: 1098115Hom.: 0 AF XY: 0.0000110 AC XY: 4AN XY: 363473
GnomAD4 exome
AF:
AC:
14
AN:
1098115
Hom.:
AF XY:
AC XY:
4
AN XY:
363473
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000903 AC: 1AN: 110779Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32949
GnomAD4 genome
AF:
AC:
1
AN:
110779
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
32949
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 15, 2017 | The c.613_615delAGT variant in the NAA10 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.613_615delAGT variant causes an in-frame deletion of one amino acid residue that is not conserved across species, denoted p.S205del. The c.613_615delAGT variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret c.613_615delAGT as a variant of uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at